Kevin Kalinsky
12PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jun 21, 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.Kevin Kalinsky, Laura Spring, Clinton Yam
|Jun 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world.Megan Kruse, Emily Nash Smyth, Lee Bowman
|Jul 02, 2021
Clinical trial data and emerging immunotherapeutic strategies: hormone receptor-positive, HER2- negative breast cancer.Matthew R Kearney, Julia E McGuinness, Kevin Kalinsky
|Jun 25, 2021
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer.Matthew Kearney, Lauren Franks, Shing Lee
|Apr 10, 2021
Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer.Madeleine B Hopson, Shing Lee, Melissa Accordino
|May 09, 2018
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial.K Kalinsky, J A Sparano, X Zhong
Pageof 2